enow.com Web Search

  1. Ads

    related to: primary axillary hyperhidrosis treatment

Search results

  1. Results from the WOW.Com Content Network
  2. Glycopyrronium tosylate - Wikipedia

    en.wikipedia.org/wiki/Glycopyrronium_tosylate

    Glycopyrronium tosylate, sold under the brand name Qbrexza among others, is a medication used for the treatment of primary axillary hyperhidrosis. [1] [2] [3] It was approved for medical use in the United States in June 2018, [4] and in Japan in January 2022. [5]

  3. Hyperhidrosis - Wikipedia

    en.wikipedia.org/wiki/Hyperhidrosis

    Hyperhidrosis is a medical condition in which a person exhibits excessive sweating, [1] [2] more than is required for the regulation of body temperature. [3] Although it is primarily a physical burden, hyperhidrosis can deteriorate the quality of life of the people who are affected from a psychological, emotional, and social perspective. [4]

  4. Focal hyperhidrosis - Wikipedia

    en.wikipedia.org/wiki/Focal_hyperhidrosis

    Focal hyperhidrosis, also known as primary hyperhidrosis, is a disease characterized by an excessive sweating localized in certain body regions (particularly palms, feet and underarms). Studies suggest that this condition, affecting between 1% and 3% of the US population, seems to have a genetic predisposition in about two thirds of those affected.

  5. Sofpironium bromide - Wikipedia

    en.wikipedia.org/wiki/Sofpironium_bromide

    Sofpironium bromide, sold under the brand name Ecclock among others, is a medication used to treat hyperhidrosis (excessive sweating). [1] Sofpironium bromide is an anticholinergic agent that is applied to the skin. [1] It was approved in Japan in 2020, for the treatment of primary axillary hyperhidrosis. [2]

  6. Here are the most common conditions, treatments, and when to see a doctor. ... “Those who have hyperhidrosis or excessive sweating are more likely to experience this,” she adds.

  7. miraDry - Wikipedia

    en.wikipedia.org/wiki/MiraDry

    miraDry is a microwave-based medical device developed by Miramar Labs which is used in the treatment of axillary hyperhidrosis. [1] It was approved by the United States Food and Drug Administration (FDA) in 2011 and was also approved in Europe. [1] miraDry selectively destroys axillary sweat glands without affecting the superficial layers of ...

  1. Ads

    related to: primary axillary hyperhidrosis treatment